These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35864015)

  • 61. Perceptions and Attitudes toward COVID-19 Vaccination among Pregnant and Postpartum Individuals.
    Siegel MR; Lumbreras-Marquez MI; James K; McBay BR; Gray KJ; Schantz-Dunn J; Diouf K; Goldfarb IT
    Am J Perinatol; 2022 Oct; 29(14):1489-1495. PubMed ID: 35709744
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Better Understanding Adult COVID-19 Vaccination Hesitancy and Refusal: The Influence of Broader Beliefs about Vaccines.
    Boyle J; Nowak G; Kinder R; Iachan R; Dayton J
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - United States, 2021-22.
    Razzaghi H; Srivastav A; de Perio MA; Laney AS; Black CL
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(42):1319-1326. PubMed ID: 36264832
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gearing Up for a Vaccine Requirement: A Mixed Methods Study of COVID-19 Vaccine Confidence Among Workers at an Academic Medical Center.
    Mahoney M; Winget M; Brown-Johnson C; de Borba L; Veruttipong D; Luu J; Jones D; Bohman B; Vilendrer S
    J Healthc Manag; 2022 May; 67(3):206-220. PubMed ID: 35576446
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coronavirus Disease 2019 (COVID-19) Vaccination Coverage, Intentions, Attitudes, and Barriers by Race/Ethnicity, Language of Interview, and Nativity-National Immunization Survey Adult COVID Module, 22 April 2021-29 January 2022.
    Ohlsen EC; Yankey D; Pezzi C; Kriss JL; Lu PJ; Hung MC; Bernabe MID; Kumar GS; Jentes E; Elam-Evans LD; Jackson H; Black CL; Singleton JA; Ladva CN; Abad N; Lainz AR
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S182-S192. PubMed ID: 35737951
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Unmet need for COVID-19 vaccination coverage in Kenya.
    Muchiri SK; Muthee R; Kiarie H; Sitienei J; Agweyu A; Atkinson PM; Edson Utazi C; Tatem AJ; Alegana VA
    Vaccine; 2022 Mar; 40(13):2011-2019. PubMed ID: 35184925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease.
    Gong JD; Barnboym E; O'Mara M; Gurevich N; Mattar M; Anthony DD; Perzynski AT; Singer NG
    Vaccine; 2024 Apr; 42(12):2994-3001. PubMed ID: 38556392
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidemiology of COVID-19 cases and vaccination coverage in Seremban District, Malaysia, 2021.
    Khairul Amin KHA; Bujang NNA; Abas SA; Zulkifli NI; Amir SA; Shah SM; Ganesan V; Aziz NF; Jalaluddin MA; Abd Wahil MS; Muhamad Hasani MH; Mohd Ali NK; Yusof MP
    Western Pac Surveill Response J; 2023; 14(2):1-7. PubMed ID: 37475779
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Vaccination coverage against COVID-19 according to country of birth, and underlying risk of severe clinical course].
    Delalic L; Hussaini L; Gjefsen HM; Gleditsch R; Winje BA; Godøy AA
    Tidsskr Nor Laegeforen; 2024 Jan; 144(1):. PubMed ID: 38258714
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of Provision of COVID-19 Vaccination in Dialysis Clinics and Patient Vaccination Coverage.
    Patel PR; Tanz LJ; Hamilton E; Swanzy K; Hymes JL; Giullian J; Novosad SA
    JAMA Intern Med; 2022 Jun; 182(6):676-678. PubMed ID: 35377396
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Strategies to improve COVID-19 vaccination coverage in Manyara region, Tanzania, July to September 2022: best practices and lessons learned.
    Mathenge V; Onuekwe C; Nass S; Akim C; Msunyaro E; Mfinanga E; Mambo WP; Mwabulambo SG; Manozas S; Kayera D; Tinuga F; Tegegne S; Mwengee W; Atuhebwe P; Zabulon Y
    Pan Afr Med J; 2023; 45(Suppl 1):3. PubMed ID: 37538365
    [No Abstract]   [Full Text] [Related]  

  • 73. Breaking Down Barriers in Vaccine Coverage.
    Maves RC; Gaglani B
    Chest; 2024 Jul; 166(1):5-6. PubMed ID: 38986642
    [No Abstract]   [Full Text] [Related]  

  • 74. COVID-19 vaccination coverage in hypertensive patients with Omicron infection: Comments on factors.
    Daungsupawong H; Wiwanitkit V
    Hum Vaccin Immunother; 2023 Dec; 19(3):2285913. PubMed ID: 37991011
    [No Abstract]   [Full Text] [Related]  

  • 75. The Last Mile Problem-Coronavirus Disease 2019 Vaccine Coverage Among the Most Socially Vulnerable.
    Titanji BK
    Clin Infect Dis; 2023 May; 76(9):1626-1627. PubMed ID: 36611245
    [No Abstract]   [Full Text] [Related]  

  • 76. Will They? Won't They? COVID-19 Vaccine Intent among Unvaccinated Young Indian Adults.
    Oka GA; Patil KH; Oka RA; Doke PP
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702858
    [No Abstract]   [Full Text] [Related]  

  • 77. COVID-19 vaccination motivation and underlying believing processes: A comparison study between individuals with affective disorder and healthy controls.
    Dalkner N; Fleischmann E; Fellendorf FT; Wagner-Skacel J; Schönthaler EMD; Bengesser S; Häussl A; Tietz S; Tmava-Berisha A; Lenger M; Reininghaus EZ
    Front Psychol; 2022; 13():935278. PubMed ID: 36562048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. COVID-19 Vaccination Rates and Predictors of Uptake Among Adults With Coronary Heart Disease: Insight From the 2022 National Health Interview Survey.
    Ezeamii VC; Ofochukwu VC; Iheagwara C; Asibu T; Ayo-Farai O; Gebeyehu YH; Kaglo EO; Odoeke MC; Adeyemi OM; Shittu HO; Okobi OE
    Cureus; 2024 Jan; 16(1):e52480. PubMed ID: 38371067
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022.
    Nguyen KH; Bao Y; Mortazavi J; Allen JD; Chocano-Bedoya PO; Corlin L
    Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250912
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Population Attributable Fraction of Nonvaccination of COVID-19 Due to Vaccine Hesitancy, United States, 2021.
    Nguyen KH; Zhao R; Chen S; Vaish AK; Bednarczyk RA; Vasudevan L
    Am J Epidemiol; 2024 Jan; 193(1):121-133. PubMed ID: 37552958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.